Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: closed-loop


Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

October 31st 2019

In this 6-month trial involving patients with type 1 diabetes, the use of a closed-loop system was associated with a greater percentage of time spent in a target glycemic range than the use of a sensor-augmented insulin pump. (NEJM)

Categories: News, Treatment
Tags: closed-loop, Type 1 Diabetes

Categories: Treatment
Tags: closed-loop, Type 1 Diabetes

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

October 16th 2019

In this 6-month trial involving patients with type 1 diabetes, the use of a closed-loop system was associated with a greater percentage of time spent in a target glycemic range than the use of a sensor-augmented insulin pump (NEJM)

Categories: Management, News
Tags: closed-loop, Type 1 Diabetes

Categories: Management
Tags: closed-loop, Type 1 Diabetes

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial

March 31st 2019

Closed-loop insulin delivery is an effective treatment option to improve glycaemic control in patients receiving nutritional support in hospital (The Lancet Diabetes & Endocrinology)

Categories: Management, News
Tags: closed-loop, inpatients

Categories: Management
Tags: closed-loop, inpatients

Participants’ Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings

February 6th 2019

While participants reported substantial benefits to using the closed loop during the day, they also identified ways in which the technology could be refined and education and training tailored to optimize effective use. Our findings suggest that mainstreaming this technology will not necessarily lead to increased demands on clinical staff (Diabetes Technology and Therapeutics)

Categories: News, Treatment
Tags: closed-loop

Categories: Treatment
Tags: closed-loop

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

October 3rd 2018

Hybrid closed-loop insulin delivery improves glucose control while reducing the risk of hypoglycaemia across a wide age range in patients with suboptimally controlled type 1 diabetes (The Lancet)

Categories: News, Treatment
Tags: closed-loop, Type 1 Diabetes

Categories: Treatment
Tags: closed-loop, Type 1 Diabetes

Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care

August 9th 2018

Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia (NEJM)

Categories: News, Treatment
Tags: closed-loop, glycaemic control, insulin, Type 2 Diabetes

Categories: Treatment
Tags: closed-loop, glycaemic control, insulin, Type 2 Diabetes

Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care

June 26th 2018

Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia (NEJM)

Categories: News, Treatment
Tags: closed-loop

Categories: Treatment
Tags: closed-loop

Faster insulin action is associated with improved glycemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes

March 30th 2017

Faster insulin action is associated with improved glycemic control during closed-loop insulin delivery and sensor-augmented pump therapy (Diabetes, Obesity and Metabolism)

Categories: News, Treatment
Tags: closed-loop, insulin, Type 2 Diabetes

Categories: Treatment
Tags: closed-loop, insulin, Type 2 Diabetes

Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial

November 18th 2016

Closed-loop insulin delivery without meal-time boluses is effective and safe in insulin-treated adults with type 2 diabetes in the general ward (The Lancet Diabetes & Endocrinology)

Categories: News, Treatment
Tags: closed-loop, hospital, Type 2 Diabetes

Categories: Treatment
Tags: closed-loop, hospital, Type 2 Diabetes

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

September 20th 2016

Hybrid closed-loop automated insulin delivery was associated with few serious or device-related adverse events in patients with type 1 diabetes (JAMA)

Categories: News, Treatment
Tags: closed-loop, Type 1 Diabetes

Categories: Treatment
Tags: closed-loop, Type 1 Diabetes

Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes

August 17th 2016

Overnight closed-loop therapy resulted in better glucose control than sensor-augmented pump therapy in pregnant women with type 1 diabetes. Women receiving day-and-night closed-loop therapy maintained glycemic control during a high proportion of the time in a period that encompassed antenatal hospital admission, labor, and delivery (NEJM)

Categories: Gestational, News
Tags: closed-loop, Type 1 Diabetes

Categories: Gestational
Tags: closed-loop, Type 1 Diabetes

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions

September 30th 2015

Our results support the use of AP at home as a safe and beneficial option for patients with type 1 diabetes. The HbA1c results are encouraging but preliminary (Lancet)

Categories: News, Treatment
Tags: closed-loop, Type 2 Diabetes

Categories: Treatment
Tags: closed-loop, Type 2 Diabetes

Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial

August 10th 2015

Twenty five percent reduction of prandial boluses during closed-loop maintains comparable glucose control in adolescents with T1D whilst lowering overall plasma insulin levels. It remains unclear whether closed-loop therapy with 25% reduction of prandial boluses will prevent postprandial hypoglycemia (Diabetes, Obesity and Metabolism)

Categories: News, Treatment
Tags: closed-loop, insulin, Type 1 Diabetes

Categories: Treatment
Tags: closed-loop, insulin, Type 1 Diabetes

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Sanofi DiabetesNovo NordiskAstraZenecaNapp Diabetes

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)Amgen

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide exercise GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership